SC 13G/A: BIOGEN INC.
Ticker: BIIB · Form: SC 13G/A · Filed: 2024-08-07T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by BIOGEN INC..
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0001086364-24-008372 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0001086364-24-008372 Filing Date 2024-08-07 Accepted 2024-08-07 16:10:26 Documents 1 Document Format Files Seq Description Document Type Size 1 us09062x1037_080724.txt SC 13G/A 12405 Complete submission text file 0001086364-24-008372.txt 14483 Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142 Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000 BIOGEN INC. (Subject) CIK : 0000875045 (see all company filings) EIN. : 330112644 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-42028 | Film No.: 241183778 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences) Mailing Address 50 HUDSON YARDS NEW YORK NY 10001 Business Address 50 HUDSON YARDS NEW YORK NY 10001 212-810-5800 BlackRock Inc. (Filed by) CIK : 0001364742 (see all company filings) EIN. : 320174431 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A SIC : 6211 Security Brokers, Dealers & Flotation Companies (CF Office: 02 Finance)